Lack of new drugs for tropical disease should not be acceptedBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7254.179/a (Published 15 July 2000) Cite this as: BMJ 2000;321:179
View Full Text
- Michael Schull, president, Médecins Sans Frontières/Doctors Without Borders (Canada) (email@example.com)
- Clinical Epidemiology Unit, Sunnybrook and Women's College Health Sciences Center, University of Toronto, Canada M4N 3M5
EDITOR—In their overview of recent advances in the treatment of common tropical infections Murray et al note the dramatic resurgence of African trypanosomiasis, which claims tens of thousands of lives annually in sub-Saharan Africa.1 They also describe the toxicity and increasing resistance associated with current drug regimens.
In their discussion of newer drugs to fight trypanosomiasis they remark that more effective drugs exist, though they are more costly and of …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.